Raptiva

Find out if you have a Raptiva® legal claim

Now Accepting Raptiva® Cases

Raptiva® is an FDA approved drug that is injected to treat moderate to severe cases of plaque psoriasis. It first became available to patients in 2003.

In 2008, The FDA altered the label for Raptiva® to warn against possibly life-threatening infections that could result from using the drug. Those infections include progressive multifocal leukoencephalopathy (PML).

By early 2009, the FDA had received four reports of patients being stricken with PML, three of whom died. This unfortunate development forced the FDA to issue a Public Health Advisory in February 2009 warning against the dangers of PML in patients using Raptiva®.

On April 8, 2009, the manufacturer of Raptiva®, Genentech Inc., issued a phased voluntary recall of the drug due to the dangers of contracting PML. As of June 8, 2009, Raptiva® was completely removed from circulation. The recall states the dangers of PML in Genentech's own words:

"PML is a rare, progressive, demyelinating disease of the central nervous system that leads to death or severe disability. PML is caused by activation of the John Cunningham, (JC) virus. The JC virus resides in latent form in up to 80 percent of healthy adults, typically only causing PML in immunocompromised patients. The factors leading to activation of the latent infection are not fully understood, though abnormalities in T-cells may be important for reactivation and PML. PML has been reported in the published literature in HIV-positive patients, as well as immunosuppressed cancer patients (including patients with hematologic malignancies), organ transplant recipients, and patients with autoimmune diseases. There are no known interventions that can reliably prevent or adequately treat PML."

If you believe a loved one has contracted PML or died from PML after using Raptiva®, you may be entitled to compensation.

Goldberg & Osborne is a law firm dedicated to helping injured people nationwide and is currently accepting cases for Raptiva® victims. For a FREE case evaluation, please call us toll-free at 1-800-THE-EAGLE (1-800-843-3245) or submit a short and simple online case form here.